TY - JOUR
T1 - Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia
T2 - An Asian-Pacific perspective and expert recommendations
AU - Sheu, Wayne H.H.
AU - Rosman, Azhari
AU - Mithal, Ambrish
AU - Chung, Namsik
AU - Lim, Yean Teng
AU - Deerochanawong, Chaicharn
AU - Soewondo, Pradana
AU - Lee, Moon Kyu
AU - Yoon, Kun Ho
AU - Schnell, Oliver
N1 - Funding Information:
Grant support: Editorial assistance was funded by an unrestricted grant from Bayer Schering Pharma.
PY - 2011/6
Y1 - 2011/6
N2 - The world is facing an epidemic of cardiovascular disease (CVD) and type 2 diabetes, with populations in low- to middle-income countries, including many in the Asia Pacific (AP) region, being disproportionately affected. Emerging data identify postprandial hyperglycaemia (PPHG) as an important predictor of CVD, and several professional bodies, including the International Diabetes Federation, have issued guidelines on the management of PPHG in type 2 diabetes. Guidance on how international recommendations could be implemented in Asian populations is currently lacking. Therefore, a panel of experts from the AP region convened to consider the current status of PPHG and CVD in the region, and to develop recommendations for clinical practice. The group concluded that improved awareness of the impact of PPHG on CVD risk, among clinicians and the general public, and more widespread use of routine screening for PPHG, using oral glucose tolerance testing in those without recognised diabetes, are required. Additionally, frequent meal-based testing and effective PPHG management are essential to the management of IGT and type 2 diabetes.
AB - The world is facing an epidemic of cardiovascular disease (CVD) and type 2 diabetes, with populations in low- to middle-income countries, including many in the Asia Pacific (AP) region, being disproportionately affected. Emerging data identify postprandial hyperglycaemia (PPHG) as an important predictor of CVD, and several professional bodies, including the International Diabetes Federation, have issued guidelines on the management of PPHG in type 2 diabetes. Guidance on how international recommendations could be implemented in Asian populations is currently lacking. Therefore, a panel of experts from the AP region convened to consider the current status of PPHG and CVD in the region, and to develop recommendations for clinical practice. The group concluded that improved awareness of the impact of PPHG on CVD risk, among clinicians and the general public, and more widespread use of routine screening for PPHG, using oral glucose tolerance testing in those without recognised diabetes, are required. Additionally, frequent meal-based testing and effective PPHG management are essential to the management of IGT and type 2 diabetes.
KW - Asia
KW - Cardiovascular disease
KW - Postprandial hyperglycaemia
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=79957995294&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2011.04.019
DO - 10.1016/j.diabres.2011.04.019
M3 - Review article
C2 - 21605924
AN - SCOPUS:79957995294
SN - 0168-8227
VL - 92
SP - 312
EP - 321
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
IS - 3
ER -